ScholarX: Journal : The Lancet

The Lancet

Journal Title

The Lancet

ISSN

E 1474-547X | P 0140-6736

Publisher

The Lancet Publishing Group

Listed on(Coverage)

JCR	1997-2019
SJR	1999-2019
CiteScore	2011-2019
SCI	2010-2019
SCIE	2010-2021
CC	2016-2021
SCOPUS	2017-2020
MEDLINE	2016-2021
EMBASE	2016-2020

Active

Active
based on the information
- SCOPUS:2020-10

Country

Aime & Scopes

Lancet is the world's leading independent general medical journal. The journal's coverage is international in focus and extends to all aspects of human health. The Lancet publishes the original primary research and review articles of the highest standard. The Lancet is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Drawing on an international network of advisers and contributors, The Lancet meets the needs of physicians by adding to their clinical knowledge and alerting them to current issues affecting the practice of medicine worldwide. The blend of challenging editorials, signed commentaries, original research, commissioned reviews, an international news section, and the views of readers in the letters pages make The Lancet an essential weekly read for physicians all over the world.

Homepage

https://www.sciencedirect.com/journal/the-lancet

Article List

1 - 20 out of 26 results.

SCIESCOPUS

9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea

Mok, J.[Mok, J.]; Lee, M.[Lee, M.]; Kim, D.K.[Kim, D.K.]; Kim, J.S.[Kim, J.S.]; Jhun, B.W.[Jhun, B.W.]; Jo, K.-W.[Jo, K.-W.]; Jeon, D.[Jeon, D.]; Lee, T.[Lee, T.]; Lee, J.Y.[Lee, J.Y.]; Park, J.S.[Park, J.S.], et al.

ArticleIssue Date2022CitationThe Lancet, v.400, no.10362, pp.1522 - 1530PublisherElsevier B.V.

SCIESCOPUS

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Sun, JM[Sun, Jong-Mu]; Shen, L[Shen, Lin]; Shah, MA[Shah, Manish A.]; Enzinger, P[Enzinger, Peter]; Adenis, A[Adenis, Antoine]; Doi, T[Doi, Toshihiko]; Kojima, T[Kojima, Takashi]; Metges, JP[Metges, Jean-Philippe]; Li, ZG[Li, Zhigang]; Kim, SB[Kim, Sung-Bae], et al.

ArticleIssue Date2021CitationLANCET, v.398, no.10302, pp.759 - 771PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study open access

Wright, NJ[Wright, Naomi J.]; Leather, AJM[Leather, Andrew J. M.]; Ade-Ajayi, N[Ade-Ajayi, Niyi]; Sevdalis, N[Sevdalis, Nick]; Davies, J[Davies, Justine]; Poenaru, D[Poenaru, Dan]; Ameh, E[Ameh, Emmanuel]; Ademuyiwa, A[Ademuyiwa, Adesoji]; Lakhoo, K[Lakhoo, Kokila]; Smith, ER[Smith, Emily Rose], et al.

ArticleIssue Date2021CitationLANCET, v.398, no.10297, pp.325 - 339PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial

Koo, BK[Koo, Bon-Kwon]; Kang, J[Kang, Jeehoon]; Park, KW[Park, Kyung Woo]; Rhee, TM[Rhee, Tae-Min]; Yang, HM[Yang, Han-Mo]; Won, KB[Won, Ki-Bum]; Rha, SW[Rha, Seung-Woon]; Bae, JW[Bae, Jang-Whan]; Lee, NH[Lee, Nam Ho]; Hur, SH[Hur, Seung-Ho], et al.

ArticleIssue Date2021CitationLANCET, v.397, no.10293, pp.2487 - 2496PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Moreau, P[Moreau, Philippe]; Dimopoulos, MA[Dimopoulos, Meletios-Athanasios]; Mikhael, J[Mikhael, Joseph]; Yong, K[Yong, Kwee]; Capra, M[Capra, Marcelo]; Facon, T[Facon, Thierry]; Hajek, R[Hajek, Roman]; Spicka, I[Spicka, Ivan]; Baker, R[Baker, Ross]; Kim, K[Kim, Kihyun], et al.

ArticleIssue Date2021CitationLANCET, v.397, no.10292, pp.2361 - 2371PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Migraine: disease characterisation, biomarkers, and precision medicine

Ashina, M[Ashina, Messoud]; Terwindt, GM[Terwindt, Gisela M.]; Al-Karagholi, MAM[Al-Karagholi, Mohammad Al-Mahdi]; de Boer, I[de Boer, Irene]; Lee, MJ[Lee, Mi Ji]; Hay, DL[Hay, Debbie L.]; Schulte, LH[Schulte, Laura H.]; Hadjikhani, N[Hadjikhani, Nouchine]; Sinclair, AJ[Sinclair, Alexandra J.]; Ashina, H[Ashina, Hakan], et al.

ArticleIssue Date2021CitationLANCET, v.397, no.10283, pp.1496 - 1504PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Migraine: integrated approaches to clinical management and emerging treatments

Ashina, M[Ashina, Messoud]; Buse, DC[Buse, Dawn C.]; Ashina, H[Ashina, Hakan]; Pozo-Rosich, P[Pozo-Rosich, Patricia]; Peres, MFP[Peres, Mario F. P.]; Lee, MJ[Lee, Mi Ji]; Terwindt, GM[Terwindt, Gisela M.]; Singh, RH[Singh, Rashmi Halker]; Tassorelli, C[Tassorelli, Cristina]; Do, TP[Thien Phu Do], et al.

ArticleIssue Date2021CitationLANCET, v.397, no.10283, pp.1505 - 1518PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

Galsky, MD[Galsky, Matthew D.]; Arija, JAA[Arranz Arija, Jose Angel]; Bamias, A[Bamias, Aristotelis]; Davis, ID[Davis, Ian D.]; De Santis, M[De Santis, Maria]; Kikuchi, E[Kikuchi, Eiji]; Garcia-del-Muro, X[Garcia-del-Muro, Xavier]; De Giorgi, U[De Giorgi, Ugo]; Mencinger, M[Mencinger, Marina]; Izumi, K[Izumi, Kouji], et al.

ArticleIssue Date2020CitationLANCET, v.395, no.10236, pp.1547 - 1557PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Hill, MD[Hill, Michael D.]; Goyal, M[Goyal, Mayank]; Menon, BK[Menon, Bijoy K.]; Nogueira, RG[Nogueira, Raul G.]; McTaggart, RA[McTaggart, Ryan A.]; Demchuk, AM[Demchuk, Andrew M.]; Poppe, AY[Poppe, Alexandre Y.]; Buck, BH[Buck, Brian H.]; Field, TS[Field, Thalia S.]; Dowlatshahi, D[Dowlatshahi, Dar], et al.

ArticleIssue Date2020CitationLANCET, v.395, no.10227, pp.878 - 887PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Paz-Ares, L[Paz-Ares, Luis]; Dvorkin, M[Dvorkin, Mikhail]; Chen, YB[Chen, Yuanbin]; Reinmuth, N[Reinmuth, Niels]; Hotta, K[Hotta, Katsuyuki]; Trukhin, D[Trukhin, Dmytro]; Statsenko, G[Statsenko, Galina]; Hochmair, MJ[Hochmair, Maximilian J.]; Ozguroglu, M[Ozguroglu, Mustafa]; Ji, JH[Ji, Jun Ho], et al.

ArticleIssue Date2019CitationLANCET, v.394, no.10212, pp.1929 - 1939PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

Ye, BD[Ye, Byong Duk]; Pesegova, M[Pesegova, Marina]; Alexeeva, O[Alexeeva, Olga]; Osipenko, M[Osipenko, Marina]; Lahat, A[Lahat, Adi]; Dorofeyev, A[Dorofeyev, Andriy]; Fishman, S[Fishman, Sigal]; Levchenko, O[Levchenko, Olena]; Cheon, JH[Cheon, Jae Hee]; Scribano, ML[Scribano, Maria Lia], et al.

ArticleIssue Date2019CitationLANCET, v.393, no.10182, pp.1699 - 1707PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Horwitz, S[Horwitz, Steven]; O'Connor, OA[O'Connor, Owen A.]; Pro, B[Pro, Barbara]; Illidge, T[Illidge, Tim]; Fanale, M[Fanale, Michelle]; Advani, R[Advani, Ranjana]; Bartlett, NL[Bartlett, Nancy L.]; Christensen, JH[Christensen, Jacob Haaber]; Morschhauser, F[Morschhauser, Franck]; Domingo-Domenech, E[Domingo-Domenech, Eva], et al.

ArticleIssue Date2019CitationLANCET, v.393, no.10168, pp.229 - 240PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Cohen, EEW[Cohen, Ezra E. W.]; Soulieres, D[Soulieres, Denis]; Le Tourneau, C[Le Tourneau, Christophe]; Dinis, J[Dinis, Jose]; Licitra, L[Licitra, Lisa]; Ahn, MJ[Ahn, Myung-Ju]; Soria, A[Soria, Ainara]; Machiels, JP[Machiels, Jean-Pascal]; Mach, N[Mach, Nicolas]; Mehra, R[Mehra, Ranee], et al.

ArticleIssue Date2019CitationLANCET, v.393, no.10167, pp.156 - 167PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

Ahmad, N[Ahmad, Nafees]; Ahuja, SD[Ahuja, Shama D.]; Akkerman, OW[Akkerman, Onno W.]; Alffenaar, JWC[Alffenaar, Jan-Willem C.]; Anderson, LF[Anderson, Laura F.]; Baghaei, P[Baghaei, Parvaneh]; Bang, D[Bang, Didi]; Barry, PM[Barry, Pennan M.]; Bastos, ML[Bastos, Mayara L.]; Behera, D[Behera, Digamber], et al.

ArticleIssue Date2018CitationLANCET, v.392, no.10150, pp.821 - 834PublisherELSEVIER SCIENCE INC

SCIESCOPUS

6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial

Hahn, JY[Hahn, Joo-Yong]; Song, YB[Song, Young Bin]; Oh, JH[Oh, Ju-Hyeon]; Cho, DK[Cho, Deok-Kyu]; Lee, JB[Lee, Jin Bae]; Doh, JH[Doh, Joon-Hyung]; Kim, SH[Kim, Sang-Hyun]; Jeong, JO[Jeong, Jin-Ok]; Bae, JH[Bae, Jang-Ho]; Kim, BO[Kim, Byung-Ok], et al.

ArticleIssue Date2018CitationLANCET, v.391, no.10127, pp.1274 - 1284PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults open access

Ezzati, M[Ezzati, Majid]; Bentham, J[Bentham, James]; Di Cesare, M[Di Cesare, Mariachiara]; Bilano, V[Bilano, Ver]; Bixby, H[Bixby, Honor]; Zhou, B[Zhou, Bin]; Stevens, GA[Stevens, Gretchen A.]; Riley, LM[Riley, Leanne M.]; Taddei, C[Taddei, Cristina]; Hajifathalian, K[Hajifathalian, Kaveh], et al.

ArticleIssue Date2017CitationLANCET, v.390, no.10113, pp.2627 - 2642PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

Kang, YK[Kang, Yoon-Koo]; Boku, N[Boku, Narikazu]; Satoh, T[Satoh, Taroh]; Ryu, MH[Ryu, Min-Hee]; Chao, Y[Chao, Yee]; Kato, K[Kato, Ken]; Chung, HC[Chung, Hyun Cheol]; Chen, JS[Chen, Jen-Shi]; Muro, K[Muro, Kei]; Kang, WK[Kang, Won Ki], et al.

ArticleIssue Date2017CitationLANCET, v.390, no.10111, pp.2461 - 2471PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Rittmeyer, A.[Rittmeyer, A.]; Barlesi, F.[ Barlesi, F.]; Waterkamp, D.[ Waterkamp, D.]; Park, K.[Park, K.]; Ciardiello, F.[ Ciardiello, F.]; von Pawel, J.[ von Pawel, J.]; Gadgeel, S.M.[ Gadgeel, S.M.]; Hida, T.[ Hida, T.]; Kowalski, D.M.[ Kowalski, D.M.]; Dols, M.C.[ Dols, M.C.], et al.

ArticleIssue Date2017CitationLANCET, v.389, no.10066, pp.255 - 265PublisherELSEVIER SCIENCE INC

SCIESCOPUS

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

Farid, TA[Farid, Talha A.]; Nejjari, C[Nejjari, Chakib]; Murray, CJL[Murray, Christopher J. L.]; Wang, HD[Wang, Haidong]; Farinha, CSES[Sa Farinha, Carla Sofia e]; Neupane, S[Neupane, Subas]; Naghavi, M[Naghavi, Mohsen]; Faro, A[Faro, Andre]; Newton, CR[Newton, Charles R.]; Allen, C[Allen, Christine], et al.

ArticleIssue Date2016CitationThe Lancet, v.388, no.10053, pp.1459 - 1544PublisherELSEVIER SCIENCE INC

SCIESCOPUS

MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study

Cho, SY[Cho, Sun Young]; Kang, JM[Kang, Ji-Man]; Ha, YE[Ha, Young Eun]; Park, GE[Park, Ga Eun]; Lee, JY[Lee, Ji Yeon]; Ko, JH[Ko, Jae-Hoon]; Lee, JY[Lee, Ji Yong]; Kim, JM[Kim, Jong Min]; Kang, CI[Kang, Cheol-In]; Jo, IJ[Jo, Ik Joon], et al.

ArticleIssue Date2016CitationLANCET, v.388, no.10048, pp.994 - 1001PublisherELSEVIER SCIENCE INC

1 2

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

The Lancet

Journal Title

ISSN

Publisher

Listed on(Coverage)

Active

Country

Aime & Scopes

Homepage

Article List

BROWSE